Screening for ovarian carcinoma: not quite there yet

The Lancet Oncology

Volumn 10, Issue 4, 2009, Pages 308-309

  Vergote, Ignace ^a   Amant, Frédéric ^a   Ameye, Lieveke ^b   Timmerman, Dirk ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Katholieke Universiteit Leuven   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ANTIGEN DETECTION; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIFFERENTIAL DIAGNOSIS; GYNECOLOGIC SURGERY; HEALTH CARE COST; HUMAN; LETTER; OVARY CANCER; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY;

FEMALE; GREAT BRITAIN; HUMANS; MASS SCREENING; OVARIAN NEOPLASMS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 63149179169     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70072-5     Document Type: Letter

References (10)

1. Menon U., Gentry-Maharaj A., Hallett R., et al. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Lancet Oncol 10 (2009) 327-340
2. Heintz A., Odicino F., Maisonneuve P., et al. Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95 suppl 1 (2006) S161-S192
3. Skates S.J., Menon U., MacDonald N., et al. Calculation of the risk of ovarian cancer from serial CA125 values for preclinical detection in postmenopauzal women. J Clin Oncol 21 (2003) 206s-210s
4. Timmerman D., De Smet F., De Brabanter J., et al. News on ultrasonographic techniques for pelvic malignancies. Int J Gynecol Cancer 13 suppl 1 (2003) 120-121
5. Granberg S., Wikland M., and Jansson I. Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol Oncol 35 (1989) 139-144
6. Timmerman D., Testa A.C., Bourne T., et al. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 23 (2005) 8794-8801
7. Crayford T.J., Campbell S., Bourne T.H., Rawson H.J., and Collins W.P. Benign ovarian cysts and ovarian cancer: a cohort study with implications for screening. Lancet 355 (2000) 1060-1063
8. Timmerman D., Schwärzler P., Collins W.P., et al. Subjective assessment of adnexal masses using ultrasonography - an analysis of interobserver variability and experience. Ultrasound Obstet Gynecol 13 (1999) 11-16
9. Valentin L., Hagen B., Tingulstad S., and Eik-Nes S. Comparison of 'pattern recognition' and logistic regression models for discrimination between benign and malignant pelvic masses. A prospective cross-validation. Ultrasound Obstet Gynecol 18 (2001) 357-365
10. Van Calster B., Timmerman D., Bourne T., et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. J Natl Cancer Inst 99 (2007) 1706-1714